About Our Company
-
We are inspired to be a premier pharmaceutical company with focus on innovative and specialty medicines
-
Our goal is to address unmet medical needs in underserved therapeutic areas and generate unparalleled value for our shareholders and partners
Our Founders & Leadership
Branimir Brankov
MD, MBA, PhD
CEO, Co-Founder, Board Member
-
Neurosurgeon and business executive
-
30+ years of pharma industry experience with Merck & Co., Inc.
-
Head of Strategic Business Intelligence
-
VP and Regional Managing Director
-
Head of International Business Development
-
-
More than 200 business development deals
Milena Brankov
MPh, MBA
Co-Founder & Board Member
-
Pharma industry professional with more than 20 years of experience in large and medium pharma companies (Pharmacia, Pfizer, IQVIA/CEGEDIM, Lupin, Muvon Therapeutics)
-
VP and Regional Managing Director
-
Global Business Development
-
Head Regulatory
-
Anna Mandinova
MD, PhD
Co-Founder & Board Member
-
Vice-Chair for Research at the Dept. of Dermatology and Assoc. Director of the CBRC at MGB
-
Assoc. Professor at Harvard Medical School
-
Associate Member of the Broad Institute of MIT/Harvard, and Affiliate Faculty of the Harvard Stem Cell Institute.
Lazar Mandinov
MD, PhD
Co-Founder & Board Member
-
Cardiologists with more than 18 years of academic experience
-
More than 20 years of industry experience in clinical development and medical affairs at start-ups and larger pharma and medical devices companies and CRO (Parexel, Edwards Lifesciences, Boston Scientific, etc)